BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10655443)

  • 1. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.
    Pagnan G; Stuart DD; Pastorino F; Raffaghello L; Montaldo PG; Allen TM; Calabretta B; Ponzoni M
    J Natl Cancer Inst; 2000 Feb; 92(3):253-61. PubMed ID: 10655443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
    Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.
    Brignole C; Pagnan G; Marimpietri D; Cosimo E; Allen TM; Ponzoni M; Pastorino F
    Cancer Lett; 2003 Jul; 197(1-2):231-5. PubMed ID: 12880987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
    Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
    Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
    J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
    Pastorino F; Mumbengegwi DR; Ribatti D; Ponzoni M; Allen TM
    J Control Release; 2008 Feb; 126(1):85-94. PubMed ID: 18166243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
    Pastorino F; Brignole C; Marimpietri D; Sapra P; Moase EH; Allen TM; Ponzoni M
    Cancer Res; 2003 Jan; 63(1):86-92. PubMed ID: 12517782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of antisense oligonucleotides in cancer.
    Pastorino F; Stuart D; Ponzoni M; Allen TM
    J Control Release; 2001 Jul; 74(1-3):69-75. PubMed ID: 11489484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligodeoxynucleotide directed against c-myb has anticancer activity and potentiates the antiproliferative effect of conventional anticancer drugs acting by different mechanisms in human colorectal cancer cells.
    Abaza MS; Al-Attiyah RJ; Al-Saffar AM; Al-Sawan SM; Moussa NM
    Tumour Biol; 2003; 24(5):241-57. PubMed ID: 15001837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.
    Brignole C; Marimpietri D; Pagnan G; Di Paolo D; Zancolli M; Pistoia V; Ponzoni M; Pastorino F
    Cancer Lett; 2005 Oct; 228(1-2):181-6. PubMed ID: 15936140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo distribution of c-myc antisense oligodeoxynucleotides local delivered by gelatin-coated platinum-iridium stents in rabbits and its effect on apoptosis.
    Zhang XX; Cui CC; Xu XG; Hu XS; Fang WH; Kuang BJ
    Chin Med J (Engl); 2004 Feb; 117(2):258-63. PubMed ID: 14975213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of effect and mechanism of c-myb on the fertilization in mouse].
    Wu LF; Zheng YH; Zhang J
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Feb; 21(1):81-5. PubMed ID: 21166174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells.
    Gholizadeh S; Dolman EM; Wieriks R; Sparidans RW; Hennink WE; Kok RJ
    Pharm Res; 2018 Mar; 35(4):85. PubMed ID: 29516187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Fab' fragments of anti-GD(2) immunoliposomes entrapping doxorubicin for experimental therapy of human neuroblastoma.
    Brignole C; Marimpietri D; Gambini C; Allen TM; Ponzoni M; Pastorino F
    Cancer Lett; 2003 Jul; 197(1-2):199-204. PubMed ID: 12880982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antisense therapeutics delivery systems: In vitro and in vivo studies of liposomes targeted with anti-CD20 antibody.
    Meissner JM; Toporkiewicz M; Czogalla A; Matusewicz L; Kuliczkowski K; Sikorski AF
    J Control Release; 2015 Dec; 220(Pt A):515-528. PubMed ID: 26585505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
    Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
    Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Met antisense oligodeoxynucleotides as a novel therapeutic agent for glioma: in vitro and in vivo studies of uptake, effects, and toxicity.
    Chu SH; Zhang H; Ma YB; Feng DF; Zhu ZA; Yuan XH; Li ZQ
    J Surg Res; 2007 Aug; 141(2):284-8. PubMed ID: 17561117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and screening of antisense oligodeoxynucleotides against PAI-1 mRNA in endothelial cells in vitro.
    Jiang QS; Wang SQ
    Acta Pharmacol Sin; 2006 Aug; 27(8):1018-23. PubMed ID: 16867253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-erbB2 and c-myb induce mouse oocyte maturation involving activation of maturation promoting factor.
    Zheng LP; Huang J; Zhang DL; Xu LQ; Li F; Wu L; Liu ZY; Zheng YH
    DNA Cell Biol; 2012 Feb; 31(2):164-70. PubMed ID: 21793718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
    Park JW; Hong K; Kirpotin DB; Colbern G; Shalaby R; Baselga J; Shao Y; Nielsen UB; Marks JD; Moore D; Papahadjopoulos D; Benz CC
    Clin Cancer Res; 2002 Apr; 8(4):1172-81. PubMed ID: 11948130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.